MedTrace Logo

Evaluating Non-Invasive Haptics During Extreme Exercise

NCT07285252 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2025-12-16

No results posted yet for this study

Summary

This study aims to compare determinants of endurance performance between participants wearing an active patch with haptic vibrotactile trigger technology (VTT) versus a placebo patch without VTT among recreational to competitive runners over a 4-week training period.

Conditions

  • VO2max
  • Lactate Threshold
  • Lactate

Interventions

DEVICE

Victory Patch with Haptic Vibrotactile Trigger Technology

Active Patch with Haptic Vibrotactile Trigger Technology

DEVICE

Sham patch

Sham/Placebo Patch without Haptic Vibrotactile Trigger Technology

Sponsors & Collaborators

  • Clarity Science LLC

    collaborator UNKNOWN

  • The Altitude Centre

    collaborator UNKNOWN

  • Vichag Healthcare Research

    collaborator UNKNOWN

  • SuperPatch Limited LLC

    lead INDUSTRY

Principal Investigators

  • Mark Sakr, DO · University of Arizona

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-05
Primary Completion
2026-08-31
Completion
2026-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07285252 on ClinicalTrials.gov